Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CTSU S1108 Principal Investigator: Carson, Kenneth
Title: A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma (SWOG S1108)
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out what effects, good and/or bad, the investigational drug, MLN8237 has on patients and their cutaneous or peripheral T-cell lymphoma.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)